FOURKITES
29.9.2021 11:14:07 CEST | Business Wire | Press release
FourKites® , the world’s leading real-time supply chain visibility platform , today introduced its Order Intelligence Hub, a new single-pane-of-glass view of the entire lifecycle of every order. By integrating order data, load information across modes, yard shipments, inventory visibility and other critical third-party systems, such as warehouse management systems and order management systems, shippers and their supply chain partners now have a powerful new tool to eliminate inefficiencies, manage exceptions, reduce expenses and increase customer satisfaction at every step of an order’s journey. With the goal of breaking down silos across systems, this solution was developed in close collaboration with major consumer packaged goods (CPG) customers and driven by insights from some of the largest companies in the Consumer Brand Association, which champions more than 1,700 leading CPG brands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210929005410/en/
As part of the recently announced Supply Chain Health and Performance Task Force , the mission of which is to increase visibility and ease supply chain pressures across the CPG industry, FourKites worked closely with Consumer Brands and 15 of its members to identify common pain points and create a solution that would address those challenges by breaking down silos between teams and systems, and leveraging the scale of the FourKites network to provide unprecedented visibility into the CPG supply chain ecosystem . Through shared dashboards, participating members can take advantage of a real-time view of facilities, lanes and interchanges causing the most inefficiencies for CPG companies. With Order Intelligence Hub, users can drill down into the line-item level impacts of bottlenecks, and can then collaborate across teams to resolve those inefficiencies.
“Collaboration is essential for building modern, resilient supply chains,” said Tom Madrecki, vice president of supply chain and logistics at Consumer Brands. “The Supply Chain Health and Performance Task Force — in partnership with FourKites — is bringing more visibility, agility and data sharing to our supply chain, allowing the CPG industry to better navigate future challenges and ensure the reliable delivery of essential goods.”
By eliminating silos and integrating disparate systems, FourKites’ Order Intelligence Hub enables collaboration and insight throughout the lifecycle of every order. Teams can much more effectively manage exceptions by identifying issues and their root causes in real time, anywhere. Customisable, persona-based dashboards provide every stakeholder group — from supply planning through to customer service and facilities management — with the data and metrics that matter most to them. And the entire community benefits from FourKites‘ market-leading network data set, collected via working with more of the world’s leading brands than any other visibility provider, including 18 of the top-20 F&B brands and nine of the top-10 CPG companies.
“The Order Intelligence Hub is a big milestone as we execute on our vision to connect the physical and digital worlds of warehouses, stores and transportation with real-time data and machine learning,” said Mathew Elenjickal, founder and CEO of FourKites. “Collaborating with our customers and other industry leaders, like Consumer Brands, in product development has enabled us to bring to market some of the most innovative solutions that address the industry’s most critical pain points.”
With the Order Intelligence Hub, FourKites builds on its long history of industry-first innovations , including multimodal purchase order tracking , which provides line-item level shipment detail using PO numbers, and Dynamic Yard , which gives enterprises the ability to proactively manage all of their facilities based on real-time, in-yard freight data and analytics. FourKites and its largest customers, which ship some of the world’s leading brands to locations around the world, have integrated previously siloed systems across customer service, transportation planning, supply/demand planning and warehouse management to enable internal stakeholder communication and insights throughout the lifecycle of every order.
About FourKites
FourKites® is a leading global supply chain visibility platform, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching 176 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 620 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210929005410/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
